Benjamin L. Palleiko - CHIEF EXECUTIVE OFFICER, Director at KalVista Pharmaceuticals, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- CHIEF EXECUTIVE OFFICER, Director
- Issuer Symbol
- KALV on Nasdaq
- All Insider Reports
- All Insider Reports
Benjamin L. Palleiko - trading volume in the past year for KalVista Pharmaceuticals, Inc.
| Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|
| Buys | ||||
| Sells | -133,295 | 100% | $15.00 | -$1,999,455 |
| Net | -133,295 | -100% | -$1,999,455 |
Holdings reported by Benjamin L. Palleiko for KalVista Pharmaceuticals, Inc.
| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 462,577 | $9,351,595 | $20.22 | 17 Apr 2026 | Direct | ||
| Restricted Stock Unit | 304,688 | $1,878,760 | $10.02 | 16 Apr 2026 | Direct | Common Stock | |
| Employee Stock Option | 113,920 | 11 Aug 2025 | Direct | Common Stock |
Transactions reported by Benjamin L. Palleiko for KalVista Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.